IHS Chemical Week

People & Business :: Companies

Rhodia Acquisition Underpins Solvay's Earnings and Sales

2:54 AM MST | February 16, 2012 | Sotirios Frantzanas

Solvay says net profits and net sales, on a proforma basis, increased 5% and 3% in the fourth quarter of 2011, to approximately €3 billion ($3.9 billion) and €122 million, respectively. Recurring Ebitda (Rebitda) and recurring Ebit (Rebit) on a proforma basis decreased 23% and 39% year over year, to €355 million and €184 million, respectively, Solvay says. The proforma basis presents Solvay's results as if last year's acquisition of Rhodia had become effective from January 1, 2010, the company says. It also harmonizes the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa